US 12233042
Treatment of cutaneous disorders
granted A61KA61K31/121A61K31/245
Quick answer
US patent 12233042 (Treatment of cutaneous disorders) held by Verrica Pharmaceuticals Inc. expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Verrica Pharmaceuticals Inc.
- Grant date
- Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/121, A61K31/245, A61K31/343, A61K9/0014